SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research
Year: 2022
Type: article
Abstract: This letter to the editor responds to comments on a recently published article on seroconversion rates after COVID-19 vaccination.
Source: The Oncologist
Institution: Hacettepe University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,494
OpenAlex ID: W4293052155
